Prediction of coronary heart disease using risk factor categories.
By Peter W. F. Wilson, R. D’Agostino, Daniel Levy, Albert M. Belanger, H. Silbershatz, W. Kannel. 1998
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Cynthia Rudin
- Benjamin Letham
- Tong Wang
- Roopesh Ranjan
- R. Riley
- Berk Ustun
- Tilmann Gneiting
- David Madigan
Citations in the corpus
- Development and validation of a prognostic index for 4-year mortality in older adults. (2006, background): “74).(34) Our index has several potential uses in clinical, policy, and research settings.”
- A new framework to enhance the interpretation of external validation studies of clinical prediction models. (2015, unknown): “and the Framingham risk scores for cardiovascular risk assessment [2].”
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis (2009, methodology): “CV risk screening and management strategies have been developed for the general population and are based on CV risk score calculators, such as the Framingham score (often used in the United States) and the Systematic Coronary Risk Evaluation (SCORE) model (often used in Europe).”
- Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. (2004, background): “Examples include the Framingham risk score for cardiovascular events (2) and the Gail model risk score for breast cancer (3).”
- Pathophysiology of human visceral obesity: an update. (2013, background): “The presence of other risk factors (623), such as insulin resistance and the metabolic syndrome (112), potentiates the deleterious impact of hypertension on target organs and CVD risk.”